UTI vs LOPE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

UTI

37.1
AI Score
VS
LOPE Wins

LOPE

43.3
AI Score

Investment Advisor Scores

UTI

37score
Recommendation
SELL

LOPE

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric UTI LOPE Winner
Revenue 661.15M 840.15M LOPE
Net Income 15.54M 164.21M LOPE
Net Margin 2.4% 19.5% LOPE
Operating Income 19.27M 205.08M LOPE
ROE 4.5% 25.7% LOPE
ROA 1.7% 18.4% LOPE
Total Assets 897.86M 894.49M UTI
Cash 130.06M 58.76M UTI
Current Ratio 1.30 2.64 LOPE

Relative Price Performance (Last 90 Days)

UTI 1M: +11.3% · 3M: -11.0% LOPE 1M: -25.9% · 3M: -19.0%

Current Technical Phase

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.8 · Price: $23.00

LOPE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.0%), weak momentum, RSI 21

RSI (14): 20.7 · Price: $117.75

Fundamentals Snapshot

Metric UTI LOPE
Market Cap — —
Forward P/E 31.3 10.7
Trailing P/E 38.0 12.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.5%
Operating Margin 0.0% 0.2%
EPS 0.61 9.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LOPE is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.